Zobrazeno 1 - 8
of 8
pro vyhledávání: '"O. V. Goronkova"'
Autor:
G. G. Solopova, D. D. Baidildina, L. I. Zharikova, I. I. Kalinina, U. N. Petrova, Ye. V. Suntsova, O. V. Goronkova, L. A. Hachatryan, V. V. Sinitsina, G. A. Novichkova, A. A. Maschan, M. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-15 (2022)
Standard therapy of high risk patients with Langerhans cell histiocytosis (LCH) is associated with essential risk of therapy failure. In the present study results of 2-clorodeoxyadenosine usage as alternative therapy in this group of patients are ana
Externí odkaz:
https://doaj.org/article/aff35ebb6ec14d3cbe54f0f6a680cf5f
Autor:
A. K. Ignatova, I. I. Kalinina, D. A. Venev, T. Yu. Salimova, D. A. Evseev, M. N. Sadovskaya, O. V. Goronkova, V. E. Matveev, U. N. Petrova, K. S. Antonova, D. D. Baydildina, M. E. Dubrovnaya, T. V. Konyukhova, Yu. V. Olshanskaya, D. S. Abramov, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 16, Iss 1, Pp 10-22 (2021)
Background. Extramedullary infiltration (EI) is relatively common in children with acute myeloid leukemia (AML) (up to 20-25 %). However, its clinical and prognostic significance remains poorly understood.Objective: to describe clinical features and
Externí odkaz:
https://doaj.org/article/14fb36d0acc24523992dfb11fa1cebf2
Autor:
I. I. Kalinina, M. M. Shneyder, N. P. Kirsanova, D. D. Baydildina, E. V. Suntsova, O. V. Goronkova, L. A. Khachatryan, G. A. Novichkova, M. A. Maschan, R. I. Yutskevich, E. V. Volochnik, T. V. Savitskaya, N. V. Minakovskaya, I. V. Proleskovskaya, I. V. Emelyanova, O. V. Karas, N. V. Migal, Yu. E. Mareyko, A. G. Drekov, J. V. Rumyantseva, E. V. Fleyshman, T. V. Nasedkina, O. V. Aleynikova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 1, Pp 11-19 (2014)
A t(8;21) is the most frequent abnormality in AML in children. Patients with this genetic abnormality are traditionally expected favorable prognosis with a probability of cure up to 80 %. Known additional cytogenetic abnormalities in AML with t(8;21)
Externí odkaz:
https://doaj.org/article/61550d5fd7a3461ea6fbd41aa62aeae6
Autor:
I. I. Kalinina, D. D. Baydildina, E. V. Suntsova, O. V. Goronkova, L. A. Khachatryan, U. N. Petrova, G. G. Solopova, V. V. Sinitsina, G. A. Novichkova, M. A. Maschan, D. V. Litvinov, N. V. Myakova, G. A. Klyasova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 3, Pp 24-34 (2014)
Candidemia is one of the most serious infectious complications in children with hematological malignancies and has a high morta lity rate.Seven-year experience of candidemia diagnosis and therapy in patients with various hematologic malignancies w as
Externí odkaz:
https://doaj.org/article/0b63a6c394fb460e8e396ab73b2366ad
Autor:
I. I. Kalinina, U. N. Petrova, O. V. Goronkova, D. D. Baidildina, V. V. Sinitsyna, L. A. Khachatryan, M. A. Maschan, G. A. Klyasova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 7, Iss 4, Pp 35-42 (2014)
Worldwide distribution of mold fungi and their extremely danger for immune compromise patients makes this issue one of the unsolved problems in modern oncology. Three cases of rare fungal infections in children with hematological malignancies are des
Externí odkaz:
https://doaj.org/article/5a921c6c078f49ea92b004e8e3471baa
Autor:
I. I. Kalinina, D. A. Venyov, Yu. V. Olshanskaya, M. N. Sadovskaya, O. V. Goronkova, T. Yu. Salimova, U. N. Petrova, D. D. Baidildina, E. V. Suntsova, D. A. Evseev, V. E. Matveev, K. S. Antonova, I. G. Khamin, M. Е. Dubrovina, E. A. Zerkalenkova, M. V. Gaskova, A. M. Popov, S. A. Kashpor, A. I. Mandzhieva, T. V. Konyukhova, L. A. Khachatryan, D. V. Litvinov, D. N. Balashov, L. N. Shelikhova, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:20-35
Over the past years, the outcomes of patients with acute myeloid leukemia (AML) have significantly improved due to the use of intensive chemotherapy, more effective supportive therapy, and the availability of allogeneic hematopoietic stem cell transp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::552ffa7a0d0e84579992ae4d12a8081b
https://doi.org/10.24287/1726-1708-2022-21-1-20-35
https://doi.org/10.24287/1726-1708-2022-21-1-20-35
Autor:
G A Novichkova, M A Maschan, I P Shipitsyna, Yu V Skvortsova, M I Persiantseva, L L Lebedeva, V O Bobrynina, D D Baidildina, O V Goronkova, G G Solopova, L A Khachatryan, U N Petrova, E V Suntsova, I I Kalinina, V V Sinitsyna, E V Skorobogatova, D N Balashov, Z M Dyshlevaya, L N Shelikhova, E E Kurnikova, P E Trakhtman, A A Maschan
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 41-47 (2010)
Aim. To analyze the efficiency of transplantation of the bone marrow from a HLA-compatible unrelated donor and continued immunosuppressive therapy (IST) in children with aplastic anemia (AA) unresponsive to 2 courses of IST. Subjects and methods. The
Externí odkaz:
https://doaj.org/article/a539b74b2830479ca8268ed25335826e
Autor:
Z M Dyshlevaya, E V Skorobogatova, M A Maschan, I P Shipitsyna, Yu V Skvortsova, P E Trakhtman, D N Balashov, Yu V Pashko, E E Kurnikova, E V Suntsova, O V Goronkova, G G Solopova, D D Baidildina, I I Kalinina, L A Khachatryan, M M Shneider, A A Maschan
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 34-40 (2010)
Aim. To analyze the results of allogeneic and autologous hemopoietic cell transplantations (allo- and auto-HCT) in children with acute myeloid leukemia (AML) from an intermediate risk group, most of which were performed using lower-intensity conditio
Externí odkaz:
https://doaj.org/article/10dd86ccbaa341b7856c227fcea1b525